Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Adverse Drug Event

rosiglitazone has been researched along with Adverse Drug Event in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (28.57)29.6817
2010's18 (64.29)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Califf, RM; Demets, D; George, JT; Gerstein, HC; Granger, C; Green, JB; Hobbs, T; Holman, RR; Lawson, FC; Leiter, LA; McGuire, DK; McMurray, J; Pagidipati, NJ; Pfeffer, MA; Reusch, J; Riesmeyer, JS; Roe, MT; Rosenberg, Y; Sharma, A; Temple, R; Wiviott, S1
Bandhakavi, S; Chen, M; Dirven, H; Fitch, SE; Kincaid, B; Leenaars, CHC; Mehta, J; Pound, P; Ram, R; Tsaioun, K; Vist, GE; Wright, RA1
Trachtman, H1
Azeloglu, EU; Badimon, JJ; Benard, L; Chen, Y; Giannarelli, C; Goldfarb, J; Gottesman, O; Hajjar, RJ; Iyengar, R; Nishimura, T; Zafar, MU; Zhao, S1
Dangi-Garimella, S1
Kesselheim, AS; Sarpatwari, A; Yeh, JS1
Borch-Johnsen, K; Fischer, KE; Hostenkamp, G1
Andrade, L; Libório, AB; Pereira, LV; Sanches, TR; Seguro, AC; Shimizu, MH1
Roses, AD1
Bernene, J; Bower, B; Hanks, S; Holford, TR; Kocherla, M; Petit, WA; Ruaño, G; Seip, RL; Wencker, D; Windemuth, A1
Strahlman, E1
Ledford, H1
Alderton, C; Craft, S; Egginton, S; Gold, M; Irizarry, M; Landreth, G; Linnamägi, U; Saunders, AM; Sawchak, S; Zvartau-Hind, M1
Curtis, B; Hall, GC; McMahon, AD; Smith, HT1
Koch, A1
Chen, J; He, L; Luo, H; Mikailov, M; Shi, L; Wang, K; Yang, L; Zhu, H1
Ciudin, A; Hernandez, C; Simó, R1
Avorn, J1
Huang, Y; Mahley, RW; Roses, AD; Saunders, AM; Strum, J; Weisgraber, KH1
Barry, PJ; Gallagher, P; Ryan, C1

Reviews

5 review(s) available for rosiglitazone and Adverse Drug Event

ArticleYear
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review.
    Scientific reports, 2021, 03-18, Volume: 11, Issue:1

    Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Liver; Rosiglitazone; Troglitazone

2021
The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:1

    Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Biomarkers, Pharmacological; Clinical Trials as Topic; Cost-Benefit Analysis; Dideoxynucleosides; Drug Discovery; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; Genotype; HLA-B Antigens; Humans; Models, Biological; Pharmacogenetics; Rosiglitazone; Sample Size; Thiazolidinediones

2009
Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology.
    Current topics in medicinal chemistry, 2012, Volume: 12, Issue:6

    Topics: Animals; Cardiovascular Diseases; Chemistry, Pharmaceutical; Drug-Related Side Effects and Adverse Reactions; Humans; Ligands; Pioglitazone; PPAR gamma; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones

2012
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    The pharmacogenomics journal, 2007, Volume: 7, Issue:1

    Topics: Alzheimer Disease; Apolipoproteins E; Biomarkers; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Genome, Human; Genotype; Humans; Pharmacogenetics; Rosiglitazone; Thiazolidinediones

2007
Inappropriate prescribing in geriatric patients.
    Current psychiatry reports, 2008, Volume: 10, Issue:1

    Topics: Accidental Falls; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Cognition Disorders; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Mobility Limitation; Pharmacokinetics; Psychotropic Drugs; Risk Factors; Rosiglitazone; Sleep Wake Disorders; Thiazolidinediones; Treatment Outcome

2008

Trials

1 trial(s) available for rosiglitazone and Adverse Drug Event

ArticleYear
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.
    Dementia and geriatric cognitive disorders, 2010, Volume: 30, Issue:2

    Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Cholinesterase Inhibitors; Donepezil; Drug-Related Side Effects and Adverse Reactions; Edema; Female; Genotype; Humans; Hypoglycemic Agents; Indans; Intelligence Tests; Interview, Psychological; Male; Middle Aged; Nasopharyngitis; Piperidines; PPAR gamma; Rosiglitazone; Thiazolidinediones; Treatment Outcome

2010

Other Studies

22 other study(ies) available for rosiglitazone and Adverse Drug Event

ArticleYear
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors

2012
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
    Circulation, 2020, 03-10, Volume: 141, Issue:10

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Glucose; Glycated Hemoglobin; Glycine; Government Regulation; Humans; Hypoglycemic Agents; Oxazoles; Phenylbutazone; Practice Guidelines as Topic; Risk; Rosiglitazone; Tolbutamide; United States; United States Food and Drug Administration

2020
Drugs and trials: lessons from Plato.
    Clinical therapeutics, 2013, Volume: 35, Issue:5

    Topics: Clinical Trials as Topic; Drug Approval; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Humans; Practice Patterns, Physicians'; Professional Misconduct; Risk Assessment; Rosiglitazone; Scientific Misconduct; Thiazolidinediones; United States; United States Food and Drug Administration

2013
Systems pharmacology of adverse event mitigation by drug combinations.
    Science translational medicine, 2013, Oct-09, Volume: 5, Issue:206

    Topics: Adverse Drug Reaction Reporting Systems; Animals; Blood Coagulation; Confounding Factors, Epidemiologic; Databases as Topic; Diabetes Mellitus, Experimental; Drug Combinations; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Exenatide; Heart Function Tests; Humans; Mice; Myocardial Infarction; Peptides; Plasminogen Activator Inhibitor 1; Rosiglitazone; Systems Biology; Thiazolidinediones; Thrombelastography; Ultrasonography; United States; United States Food and Drug Administration; Venoms

2013
The Yin and the Yang of CV risks in patients with diabetes.
    The American journal of managed care, 2014, Volume: 20, Issue:8 Spec No.

    Topics: Adamantane; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptides; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Heart Rate; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Myocardial Infarction; Pioglitazone; Risk Assessment; Rosiglitazone; Safety-Based Drug Withdrawals; Stroke; Thiazolidinediones; United States; United States Food and Drug Administration

2014
Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Drug safety, 2016, Volume: 39, Issue:8

    Topics: Drug Approval; Drug Industry; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Legislation, Drug; Prescription Drugs; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Varenicline

2016
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark.
    Health policy (Amsterdam, Netherlands), 2016, Volume: 120, Issue:12

    Topics: Denmark; Diabetes Mellitus, Type 2; Drug Interactions; Drug Labeling; Drug Prescriptions; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Germany; Humans; Hypoglycemic Agents; Pioglitazone; Rosiglitazone; Thiazolidinediones

2016
Rosiglitazone reverses tenofovir-induced nephrotoxicity.
    Kidney international, 2008, Volume: 74, Issue:7

    Topics: Adenine; Animals; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Hypoglycemic Agents; Hypophosphatemia; Hypophosphatemia, Familial; Kidney Diseases; Male; Membrane Transport Proteins; Organophosphonates; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Rosiglitazone; Tenofovir; Thiazolidinediones

2008
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
    Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 400, Issue:1-2

    Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Edema; Female; Genomics; Genotype; Humans; Hypoglycemic Agents; Male; Middle Aged; Phenotype; Pioglitazone; Polymorphism, Single Nucleotide; Retrospective Studies; Rosiglitazone; Thiazolidinediones

2009
Response to "Rosiglitazone no longer recommended".
    Lancet (London, England), 2009, Feb-14, Volume: 373, Issue:9663

    Topics: Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Randomized Controlled Trials as Topic; Reproducibility of Results; Rosiglitazone; Thiazolidinediones

2009
Diabetes drug safety update: Avandia and your heart.
    The Johns Hopkins medical letter health after 50, 2010, Volume: 22, Issue:4

    Topics: Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Myocardial Infarction; Risk Factors; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration

2010
Effective approach.
    Nature, 2010, Jul-22, Volume: 466, Issue:7305

    Topics: Diabetes Mellitus; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Health Care Rationing; Humans; Pioglitazone; Rosiglitazone; Thiazolidinediones

2010
Diabetes drugs offered fresh start.
    Nature, 2010, Jul-22, Volume: 466, Issue:7305

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Humans; Mice; Myocardial Infarction; PPAR gamma; Risk; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration

2010
Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning.
    International journal of clinical practice, 2011, Volume: 65, Issue:5

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Family Practice; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Practice Patterns, Physicians'; Risk Factors; Rosiglitazone; Safety-Based Drug Withdrawals; Thiazolidinediones; United Kingdom

2011
[Benefits and harms - two sides of the same medal?].
    Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2011, Volume: 105, Issue:3

    Topics: Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Germany; Humans; Hypoglycemic Agents; Insurance, Pharmaceutical Services; Product Surveillance, Postmarketing; Risk Assessment; Rosiglitazone; Survival Analysis; Thiazolidinediones

2011
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome.
    Nucleic acids research, 2011, Volume: 39, Issue:Web Server

    Topics: Anti-Infective Agents; Antipsychotic Agents; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Internet; Ligands; Pharmaceutical Preparations; Proteins; Rosiglitazone; Software; Thiazolidinediones

2011
Two centuries of assessing drug risks.
    The New England journal of medicine, 2012, Jul-19, Volume: 367, Issue:3

    Topics: Databases, Factual; Drug and Narcotic Control; Drug Evaluation; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethylene Glycols; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Lactones; Pharmaceutical Preparations; Rosiglitazone; Sulfanilamide; Sulfanilamides; Sulfones; Thiazolidinediones; United States; United States Food and Drug Administration

2012
Rosiglitazone: seeking a balanced perspective.
    Lancet (London, England), 2007, Jun-02, Volume: 369, Issue:9576

    Topics: Adult; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Myocardial Infarction; Periodicals as Topic; Rosiglitazone; Thiazolidinediones

2007
Ensuring drug safety: lessons from the thiazolidinediones.
    Lancet (London, England), 2007, Sep-29, Volume: 370, Issue:9593

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hyperglycemia; Hypoglycemic Agents; Myocardial Infarction; Rosiglitazone; Thiazolidinediones

2007